Teva Pharmaceuticals (TEVA) out with earnings late last night. Globes reports this morning that Copazone sales rose 29% year over year while overall sales increased 18% over 2007. Reporting $2.82 billion over analysts’ expectations of $2.68, TEVA beat on the top line. TEVA also beat with $.65 on EPS. According to Globes, “As of July 23, 2008, Teva had 149 product applications awaiting final FDA approval, including 41 tentative approvals.”
Bank of Israel raises interest rates to 4%. Read more.
Just eight months after its launch, Sheldon Adelson’s free Hebrew daily, Yisrael Hayom, has become the second most widely circulated newspaper in Israel, edging out Maariv.
Here’s an interesting interview with VC Cafe’s Eze Vidra pitting Israel against Sand Hill Road.